Clinical Trial

Validation of the Performance of the French Version of the Cerebellar Cognitive-Affective Syndrome Scale (CCASS) as a Screening Test for Cerebellar Cognitive-affective Syndrome: a National Multicenter Study

Study acronym: CCASS-FR
Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of the study is to assess the performance of the French version of the Cerebellar Cognitive-Affective Syndrome Scale (CCASS) as a screening test for cerebellar cognitive-affective syndrome. The primary endpoint will be the sensitivity of version 1A of the French scale. The result will be considered positive if the patient fails at least one of the scale's subtests. The diagnosis of a cerebellar cognitive-affective syndrome will be made on the basis of a pathological score in the executive, language, visuospatial or psychoaffective domains of the neuropsychological evaluation (gold standard).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-08-16; most recent amendment 2025-05-13.
Status change: Not Yet Recruiting → Recruiting 2023-10-27
Trial Details
NCT Number NCT06005844
Lead Sponsor Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Conditions Cerebellar Cognitive-affective Syndrome
Enrollment 217 participants
Start Date 2023-11-09
Primary Completion 2026-10 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2025-05-16